CRONOS GROUP INC. Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted
CRONOS GROUP INC. (CRON) reported Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted · last filed 2026-02-26
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2024-09-30 was $0.00.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2023-12-31 was $124.00K.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2023-09-30 was -$182.00K.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for fiscal 2025 was $0.00.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for fiscal 2024 was $0.00.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for fiscal 2023 was -$4.11M.
- CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, diluted for fiscal 2022 was -$13.56M.
| Period end | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 9 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 12 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$58.00K derived: sum of 2 quarters · filed 2026-02-26 | -$4.11M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$182.00K 10-Q · filed 2024-11-12 | -$4.24M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | -$13.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$13.56M derived: sum of 2 quarters · filed 2025-02-27 | -$13.56M 10-K · filed 2025-02-27 | $0.00 10-K · filed 2023-02-28 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $82.00K derived: sum of 2 quarters · filed 2023-02-28 | -$479.00K derived: sum of 3 quarters · filed 2023-02-28 | -$500.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $82.00K 10-Q · filed 2022-11-07 | -$479.00K derived: sum of 2 quarters · filed 2022-11-07 | -$500.00K 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | -$561.00K 10-Q/A · filed 2022-02-18 | -$582.00K 10-Q/A · filed 2022-02-18 | |||
| 2020-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$604.00K derived: sum of 2 quarters · filed 2023-02-28 | -$650.00K derived: sum of 3 quarters · filed 2023-02-28 | -$650.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$473.00K 10-Q · filed 2022-02-18 | -$519.00K derived: sum of 2 quarters · filed 2022-02-18 | -$519.00K 10-Q · filed 2022-02-18 | ||
| 2020-06-30 | -$46.00K 10-Q/A · filed 2022-02-18 | -$46.00K 10-Q/A · filed 2022-02-18 | |||
| 2019-12-31 | -$363.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |